Condition
Multiple System Atrophy - Cerebellar Subtype (MSA-C)
Total Trials
5
Recruiting
4
Active
4
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Recruiting4
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06821256Not ApplicableRecruitingPrimary
Efficacy and Safety of Transcranial dIrect Current stiMulation in Multiple System Atrophy-Cerebellar Variant
NCT06647641Recruiting
The CurePSP Genetics Program
NCT06890377RecruitingPrimary
Targeted Α-synuclein PET Imaging in the Diagnosis of Multiple System Atrophy
NCT06890390RecruitingPrimary
TSPO PET in the Evaluation of Neuroinflammation in Patients with Multiple System Atrophy
NCT02035761Completed
PET Imaging Study of Neurochemical and Autonomic Disorders in Multiple System Atrophy (MSA)
Showing all 5 trials